Picture of BSF Enterprise logo

BSFA BSF Enterprise News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

REG - BSF Enterprise PLC - Strategic Investment

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250428:nRSb4243Ga&default-theme=true

RNS Number : 4243G  BSF Enterprise PLC  28 April 2025

London, 28 April 2025

 

BSF Enterprise PLC

 

Strategic Investment

 

BSF Enterprise PLC ("BSF" or the "Company"), a leading innovator in
tissue-engineered materials, is pleased to announce that it has conditionally
placed 4,725,000 new ordinary shares in the Company ("Placing Shares") raising
£141,750 at 3p per share in a placing ("Placing") within the Company's
remaining headroom for shares available under the Financial Conduct's
Authority Rules.

 

Shard Capital is acting as sole broker to the Company.

 

In light of the significant news on T-Rex leather last Friday we had some
small additional headroom for investment and this fundraise represents
continuing support from the Company's largest shareholder to bolster the
Company's strategic business and growth plans, with the possibility of
significant value inflection points throughout  2025.

 

Completion of the Placing is conditional on, inter alia, the Placing Shares
being admitted to listing on the Equity Shares (transition) category of the
Official List and to trading on the London Stock Exchange's main market for
listed securities ("Admission"). Admission is expected before 15 May 2025.

 

Applications will be made to the FCA and to the London Stock Exchange for
Admission in respect of all the Placing Shares proposed to be issued on
completion of the Placing.

 

The rights attaching to the Placing Shares will rank pari passu with the
existing ordinary shares of the Company. This announcement contains inside
information for the purposes of Article 7 of Regulation 2014/596/EU which is
part of domestic UK law pursuant to the Market Abuse (Amendment) (EU Exit)
regulations (SI 2019/310).

 

Contact Information For further information, please
visit: www.bsfenterprise.com (http://www.bsfenterprise.com/)

 

For further enquiries, please visit www.bsfenterprise.com or contact:

 BSF Enterprise PLC

 Geoff Baker - Executive Director

 Che Connon - CEO & Director

 Shard Capital (Broker)
 Damon Heath                       0207 186 9000

 Isabella Pierre                   0207 186 9927

 

About BSF Enterprise PLC

BSF Enterprise PLC (BSF) develops and commercialises cutting-edge
tissue-engineered solutions, including lab-grown leather, cultivated meat, and
corneal repair technologies. By leveraging its proprietary scaffold-free
platform, BSF aims to deliver sustainable alternatives to traditional
materials and meet global demand for environmentally responsible innovations.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPPUWCCUPAURR

Recent news on BSF Enterprise

See all news